Shah UH, Gonzalez-Maeso J (2019) Serotonin and glutamate interactions in preclinical schizophrenia models. ACS Chem Neurosci 10:3068–3077

Article  CAS  PubMed  Google Scholar 

Watkins JC (2000) l-glutamate as a central neurotransmitter: looking back. Biochem Soc Trans 28:297–309

Article  CAS  PubMed  Google Scholar 

Wischhof L, Koch M (2016) 5-HT2A and mGlu2/3 receptor interactions: on their relevance to cognitive function and psychosis. Behav Pharmacol 27:1–11

Article  CAS  PubMed  Google Scholar 

Chaki S (2019) mGlu2/3 receptor antagonists. Adv Pharmacol 86:97–120

Article  CAS  PubMed  Google Scholar 

Chaki S, Fukumoto K (2019) Role of serotonergic system in the antidepressant actions of mGlu2/3 receptor antagonists: similarity to ketamine. Int J Mol Sci 20:1270

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marek GJ, Wright RA, Schoepp DD, Monn JA, Aghajanian GK (2000) Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex. J Pharmacol Exp Ther 292:76–87

CAS  PubMed  Google Scholar 

González-Maeso J, Ang RL, Yuen T, Chan P, Weisstaub NV, López-Giménez JF, Zhou M, Okawa Y, Callado LF, Milligan G, Gingrich JA, Filizola M, Meana JJ, Sealfon SC (2008) Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature 452:93–97

Article  ADS  PubMed  PubMed Central  Google Scholar 

Toneatti R, Shin JM, Shah UH, Mayer CR, Saunders JM, Fribourg M, Arsenovic PT, Janssen WG, Sealfon SC, Lopez-Gimenez JF, Benson DL, Conway DE, Gonzalez-Maeso J (2020) Interclass GPCR heteromerization affects localization and trafficking. Sci Signal 13:eaaw3122

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moreno JL, Muguruza C, Umali A, Mortillo S, Holloway T, Pilar-Cuellar F, Mocci G, Seto J, Callado LF, Neve RL, Milligan G, Sealfon SC, Lopez-Gimenez JF, Meana JJ, Benson DL, Gonzalez-Maeso J (2012) Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A.mGlu2) receptor heteromerization and its psychoactive behavioral function. J Biol Chem 287:44301–44319

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gonzalez-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, Lira A, Bradley-Moore M, Ge Y, Zhou Q, Sealfon SC, Gingrich JA (2007) Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron 53:439–452

Article  CAS  PubMed  Google Scholar 

Jiang K, Liu X, Su R (2022) Contrasting effects of DOI and lisuride on impulsive decision-making in delay discounting task. Psychopharmacology 239:3551–3565

Article  CAS  PubMed  Google Scholar 

Karaki S, Becamel C, Murat S, Mannoury la Cour C, Millan MJ, Prezeau L, Bockaert J, Marin P, Vandermoere F (2014) Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists. Mol Cell Proteomics 13:1273–1285

Article  CAS  Google Scholar 

Nichols DE (2016) Psychedelics. Pharmacol Rev 68:264–355

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moreno JL, Holloway T, Albizu L, Sealfon SC, Gonzalez-Maeso J (2011) Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists. Neurosci Lett 493:76–79

Article  CAS  PubMed  PubMed Central  Google Scholar 

de la Fuente Revenga M, Shin JM, Vohra HZ, Hideshima KS, Schneck M, Poklis JL, Gonzalez-Maeso J (2019) Fully automated head-twitch detection system for the study of 5-HT2A receptor pharmacology in vivo. Sci Rep 9:14247

Article  ADS  PubMed  PubMed Central  Google Scholar 

Klodzinska A, Bijak M, Tokarski K, Pilc A (2002) Group II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in mice. Pharmacol Biochem Behav 73:327–332

Article  CAS  PubMed  Google Scholar 

Aghajanian GK, Marek GJ (1997) Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology 36:589–599

Article  CAS  PubMed  Google Scholar 

Zhai Y, George CA, Zhai J, Nisenbaum ES, Johnson MP, Nisenbaum LK (2003) Group II metabotropic glutamate receptor modulation of DOI-induced c-fos mRNA and excitatory responses in the cerebral cortex. Neuropsychopharmacology 28:45–52

Article  CAS  PubMed  Google Scholar 

Fribourg M, Moreno JL, Holloway T, Provasi D, Baki L, Mahajan R, Park G, Adney SK, Hatcher C, Eltit JM, Ruta JD, Albizu L, Li Z, Umali A, Shim J, Fabiato A, MacKerell AD Jr, Brezina V, Sealfon SC, Filizola M, Gonzalez-Maeso J, Logothetis DE (2011) Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic Drugs. Cell 147:1011–1023

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu X, Zhu H, Gao H, Tian X, Tan B, Su R (2022) Gs signaling pathway distinguishes hallucinogenic and nonhallucinogenic 5-HT2AR agonists induced head twitch response in mice. Biochem Biophys Res Commun 598:20–25

Article  CAS  PubMed  Google Scholar 

Benvenga MJ, Chaney SF, Baez M, Britton TC, Hornback WJ, Monn JA, Marek GJ (2018) Metabotropic glutamate2 receptors play a key role in modulating head twitches induced by a serotonergic hallucinogen in mice. Fronti Pharmacol 9:208

Article  Google Scholar 

Gewirtz JC, Marek GJ (2000) Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors. Neuropsychopharmacology 23:569–576

Article  CAS  PubMed  Google Scholar 

Knudsen GM (2023) Sustained effects of single doses of classical psychedelics in humans. Neuropsychopharmacology 48:145–150

Article  CAS  PubMed  Google Scholar 

Nichols DE (2004) Hallucinogens. Pharmacol Ther 101:131–181

Article  CAS  PubMed  Google Scholar 

Canal CE, Morgan D (2012) Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model. Drug Test Anal 4:556–576

Article  CAS  PubMed  PubMed Central  Google Scholar 

Halberstadt AL, Geyer MA (2013) Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement. Psychopharmacology 227:727–739

Article  CAS  PubMed  Google Scholar 

Moreno JL, Holloway T, Rayannavar V, Sealfon SC, Gonzalez-Maeso J (2013) Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice. Neurosci Lett 536:69–73

Article  CAS  PubMed  PubMed Central  Google Scholar 

Halberstadt AL, van der Zee JVF, Chatha M, Geyer MA, Powell SB (2019) Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen. Psychopharmacology 236:821–830

Article  CAS  PubMed  Google Scholar 

Rorick-Kehn LM, Johnson BG, Burkey JL, Wright RA, Calligaro DO, Marek GJ, Nisenbaum ES, Catlow JT, Kingston AE, Giera DD, Herin MF, Monn JA, McKinzie DL, Schoepp DD (2007) Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039). J Pharmacol Exp Ther 321:308–317

Article  CAS  PubMed  Google Scholar 

Fell MJ, Svensson KA, Johnson BG, Schoepp DD (2008) Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039). J Pharmacol Exp Ther 326:209–217

Article  CAS  PubMed  Google Scholar 

Delille HK, Mezler M, Marek GJ (2013) The two faces of the pharmacological interaction of mGlu2 and 5-HT(2)A - relevance of receptor heterocomplexes and interaction through functional brain pathways. Neuropharmacology 70:296–305

Article  CAS  PubMed  Google Scholar 

Garcia EE, Smith RL, Sanders-Bush E (2007) Role of G(q) protein in behavioral effects of the hallucinogenic drug 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane. Neuropharmacology 52:1671–1677

Article  CAS  PubMed  PubMed Central  Google Scholar 

Albizu L, Holloway T, Gonzalez-Maeso J, Sealfon SC (2011) Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors. Neuropharmacology 61:770–777

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vinals X, Moreno E, Lanfumey L, Cordomi A, Pastor A, de La Torre R, Gasperini P, Navarro G, Howell LA, Pardo L, Lluis C, Canela EI, McCormick PJ, Maldonado R, Robledo P (2015) Cognitive impairment induced by delta9-tetrahydrocannabinol occurs through heteromers between cannabinoid CB1 and serotonin 5-HT2A receptors. PLoS Biol 13:e1002194